Bladder Cancer Survivor - Maynard's Envita Review

When Maynard saw blood in his urine, he knew something was wrong. A CT scan revealed a large mass in his bladder, which needed further investigation. A biopsy revealed an aggressive form of stage 3 bladder cancer. Maynard's doctors suggested bladder and prostate removal as his only options.

“If we just remove those parts, is there cancer somewhere in my body? Nobody is talking about that outside of Envita,” said Maynard, who travelled all the way from Maine to Arizona for a more precision approach to cancer care than standard oncology. Envita Medical Centers, a world-class integrative center of personalized precision oncology, aims to overcome this challenge with sophisticated algorithms developed over a period of 25 years treating complex and late-stage cancer patients.

Firm Resolve for Envita

Maynard and his wife were devastated with the diagnosis. Luckily, a friend informed the couple about his sister's successful cancer treatment at Envita Medical Centers. She told us, “Don't even waste time with conventional care, just come straight here!”

The encouraging response from a cancer survivor treated at Envita firmed his resolve to seek their precision oncology options. Maynard is ecstatic about his decision because after completing his treatment at Envita there is “no evidence of tumor” in his body.

Envita's Unique Treatment Approach

To achieve such results which seem miraculous to many cancer patients, the expert medical team at Envita uses cutting-edge advanced technologies in combination with the latest natural therapies. Their personalized treatment approach is based on the four pillars of extensive genomic analysis, immunotherapy, customized drug design, and precision deployment, with the goal of their patients' holistic recovery. “The focus was not just on my cancer, but it was on my whole health,” said Maynard.

Extensive Genomic Overview

The first step in Envita's personalized precision approach is an extensive genomic analysis, which is not accessible to 80 percent of the patients in standard oncology. Even the 20 percent who get some form of precision in standard oncology are not tested on as many parameters as Envita's patients.

The result of this in-depth analysis leads Envita's expert team to better understand each patient's unique cancer expressions, helping them customize a patient-specific medical blueprint. Armed with custom designed chemotherapy and immunotherapy agents targeted to each patient's specific cancer mutations and administered with precision deployment, the expert team at Envita aims to attack cancer from all possible angles.

Envita's Proprietary Precision Targeted Treatments

GTFC™ is an instrumental precision targeted treatment that was used in Maynard's case with fantastic results. Genetically Targeted Fractionated Chemotherapy (GTFC™) uses a metronomic dosage of chemotherapy, which may be 10 to 20 percent of what is administered in untargeted maximum therapeutic dose chemotherapy. The low dose chemotherapy reduces the chance of impact on the surrounding healthy cells. With your healthy cells remaining intact, your immune system does not get affected, which is why our patients rarely experience any side-effects.

A stronger immune system is better equipped to deal with the cancer, so our focus is on building the patients' immunity while treating their disease to pave their route to recovery. “I am going to live, and I'm going to live a quality of life that I'm okay with, and I'm going to keep my bladder,” said a relived and contented Maynard, who wants to encourage everyone to come to Envita for their cancer treatment.

Call Us Today

The expert team at Envita includes oncologists, interventional radiologists, researchers, and pharmacists who collaborate to design a unique treatment plan, aimed at improving patient quality of life, increasing longevity, and reducing toxicity. If you or any of your loved ones have questions regarding cancer, please feel free to call us at 866-830-4576.